Entrepreneur
Human Health raises £4.1m for precision care
Human Health has raised £4.1m seed funding to expand its precision health platform for patients with chronic conditions and accelerate UK rollout.
The company’s “Precision Health OS” is an operating system-style platform that uses patient-reported data and AI to tailor care. Patients can track symptoms, treatments and routines, detect patterns and share doctor-ready reports.
More than 41 per cent of UK adults live with a longstanding health condition, with six million on lengthy waiting lists. Human Health says its tools help people act between appointments, not just wait.
More than 200,000 patients have recorded over 20 million health actions on the platform, with over 40,000 logged each day. The company will also expand research partnerships through its B2B product, Human Evidence.
Co-founder Kate Lambridis said: “Our mission is simple: to give everyone access to personalised healthcare. Right now, too many people are left in limbo; stuck on waiting lists, repeating their stories to different doctors, and trying to make sense of complex conditions without the right tools. Human Health is designed to change that. By helping patients capture their own health data, track what’s working, and share those insights with clinicians, we put them back in control of their journey. Patients don’t have to just wait; they can act, self-advocate, and build the kind of real-world evidence that leads to faster answers and better outcomes. This will create the world’s largest observational data set on chronic disease, all powered by patient choice.”
Co-founder Georgia Vidler said: “We’ve designed Human Health as a true Precision Health OS, a central hub where patients can make sense of their data, patterns and progress. But this is just the beginning. Our goal is to put patients at the centre of medicine itself, at the centre of their own care, and at the centre of how we move medical research forward. By connecting lived experience with real-world data, we can build a healthcare system that learns from patients, not just treats them.”
The round was backed by LocalGlobe, Airtree and Skip Capital, with angels including Arvind Rajan, Eric Salama and David Shein.
Julia Hawkins, general partner at LocalGlobe, said: “More than 41 per cent of UK adults are living with a longstanding health condition in the UK. In the US, 60 per cent of adults live with a chronic condition. I understand deeply the challenges people with long-term health issues face when trying to get answers in a system built to treat, not to understand. We need to empower individuals to make sense of their own health data in order to enable truly personalised care. We’re thrilled to partner with Human Health to build the data infrastructure that will power this generational shift in healthcare.”
Stanford graduates’ startup Clair is building a wearable hormone tracker for women, offering continuous, non-invasive monitoring.
The company, Clair, founded by Jenny Duan and Abhinav Agarwal, aims to build what its founders describe as a research-led, privacy-focused tool to help women see how hormone levels affect daily life.
Duan and Agarwal met in spring 2025 and began working on Clair shortly after. Over the past six months, they have been developing the technology and refining the company’s mission.
The device is designed to address gaps in women’s healthcare. Women remain underrepresented in medical research and clinical trials, leading to limited data and slower progress in understanding women’s health conditions.
According to Clair advisor and Stanford Medicine professor Brindha Bavan, hormone tracking in reproductive healthcare “improves our understanding of the function of and communication between the brain’s pituitary gland and ovaries or testes.
The pituitary gland is a small organ at the base of the brain that produces hormones regulating many bodily functions. The ovaries and testes are the primary reproductive organs that also produce sex hormones.
Hormonal health affects not only fertility and reproduction but also mental health, metabolism, energy levels and overall wellbeing.
Bavan said hormone tracking can “provide insight into menstrual cycle patterns and can aid with both diagnosing and assessing treatment for [various] conditions.”
“[Clair enables] patients [to] gain insight into their personal hormone fluctuations over different time periods,” Bavan said, “and share this information at healthcare visits to better understand and correlate any medical issues they are facing and avoid repeat blood draws.”
The device, which resembles a bracelet worn on the wrist, will connect to a mobile app, allowing all data processing to occur directly on the user’s phone rather than in external data centres.
“The device connects with an app so all of the processing happens on the app itself, not in a data centre like other devices. This is especially important given the current political climate around data privacy,” Agarwal said.
Clair also plans to pursue FDA approval and position itself as a medically credible device rather than solely a lifestyle product. The company is planning to launch a clinical trial at Stanford Medicine this spring.
Duan’s interest in women’s health and technology began as a Stanford undergraduate. At TreeHacks in 2024, she built apps focused on endometriosis, a condition where tissue similar to the lining of the womb grows outside of it.
She said a course on Philanthropy for Sustainable Development was particularly influential. “It was this class that sparked my interest in building a solution in [the women’s healthcare] space,” Duan said.
Rapidly scaling startups often make rushed hiring choices that disadvantage women, a recent study has found.
The findings draw on more than 31,000 new ventures founded in Sweden between 2004 and 2018.
Researchers at the Stockholm School of Economics report that in male-led startups, scaling reduces the odds of hiring a woman by about 18 per cent, and the odds of appointing a woman to a managerial post by 22 per cent.
Mohamed Genedy is co-author and postdoctoral fellow at the House of Innovation, Stockholm School of Economics.
Genedy said: “During those moments of rapid growth, even well-intentioned leaders can fall back on familiar stereotypes when assessing who they believe is best suited for the role.”
The patterns emerge even in Sweden, regarded as a highly gender-equal national context.
Founders with human resources-related education counteract these challenges.
In ventures led by founders with HR training, the odds of hiring a woman increase by more than 30 per cent, and the odds of appointing a woman to a managerial role increase by 14 per cent for the same level of growth.
Genedy said: “When founders have experience with structured hiring practices, the gender gaps shrink, and in some cases even reverse.
“This shows that getting the basics of HR right early on really pays off.
“When things start moving fast, founders with HR knowledge are less likely to rely on biased instincts and more likely to hire from a broader talent pool.”
Prior experience in companies with established HR practices also helps, though to a lesser degree.
It raises the likelihood of hiring women as ventures scale, but does not significantly affect managerial appointments.
The study additionally shows these patterns are not driven by founder gender alone.
Even solo female-led ventures display similar tendencies when growing rapidly, though to a somewhat lesser degree.
In female-dominated industries, rapid growth increases the hiring of women for regular roles but still reduces the likelihood that women are appointed to managerial positions.
“When scaling accelerates, cognitive bias kicks in for everyone. Female founders are not immune to these patterns,” said Genedy.
Midi Health has closed a US$100m Series D, lifting the menopause care provider to a valuation above US$1bn and achieving unicorn status.
The company, originally focused on virtual menopause care, says it will expand to what it calls lifelong care, adding cardiology, obesity management, autoimmune survivorship and longevity services.
Joanna Strober is co-founder and chief executive officer of Midi Health.
She said: “This is validation for the movement we’re leading.
“Women’s health has been treated like an afterthought for too long.”
Midi reports it now sees more than 25,000 patients per week and has insurance coverage reaching 45 million women nationwide.
To support scale, the firm is rolling out a proprietary artificial intelligence engine intended to slot into clinical workflows.
It analyses patient charts before virtual visits to help personalise care, automates triage and documentation, and reviews data on midlife women to refine protocols.
The company has also strengthened its leadership. Jason Wheeler, formerly in senior finance roles at Tesla and Google, has been appointed chief financial officer. He joins chief marketing officer Melissa Waters, previously at Meta and Lyft, and chief commercial officer Matt Cook.
Each year, about two million women in the US enter menopause.
Untreated symptoms are estimated to cost the economy US$25bn annually.
-
Features4 weeks agoWomen’s health enters a new era – the trends shaping femtech in 2026
-
Insight4 weeks agoDesigner perfumes recalled over banned chemical posing fertility risk
-
Features4 weeks agoBest menopause apps and products for 2026
-
Insight2 weeks agoParents sue IVF clinic after delivering someone else’s baby
-
Insight3 weeks agoWomen’s health could unlock US$100bn by 2030
-
Insight4 weeks agoHigher maternal blood pressure increases risk of pregnancy complications, study finds
-
Hormonal health4 weeks agoXella Health closes US$3.7 million in pre-seed financing
-
Insight4 weeks agoInside the first wave of speakers confirmed for Women’s Health Week USA 2026